forphenicinol has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, S; Miyasato, H; Saito, K; Suzuki, T; Tajima, K; Terakado, T | 1 |
| Hayasaka, K; Ishihara, K; Yamazaki, N | 1 |
2 other study(ies) available for forphenicinol and Skin Neoplasms
| Article | Year |
|---|---|
[Phase I study of forphenicinol, a new biological response modifier].
Topics: Adjuvants, Immunologic; Drug Administration Schedule; Drug Evaluation; Glycine; Humans; Skin Neoplasms | 1983 |
Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan.
Topics: Biological Factors; Biological Products; Cell Wall Skeleton; Cytokines; DNA, Bacterial; Glycine; Humans; Interferon Type I; Interferon-gamma; Interferons; Interleukin-2; Leucine; Male; Melanoma; Middle Aged; Mucoproteins; Mycolic Acids; Picibanil; Recombinant Proteins; Skin Neoplasms; Tumor Necrosis Factor-alpha | 1989 |